ArticleNeurology international2025

The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients.

Eleonora Virgilio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.